Paul Barragan

Showing 1-5 of 5 articles

A novel method to quantitate bioprosthetic valve leaflet mechanical stress: a numerical and in vitro study

Stanová V, Godio Raboutet Y, Masson C, Py M, Barragan P, Thollon L, Rieu R, Pibarot P

September 20, 2019 | 10.4244/EIJ-D-19-00327

Interventions for valvular disease

Effect of size and position of self-expanding transcatheter valve on haemodynamics following valve-in-valve procedure in small surgical bioprostheses: an in vitro study

Zenses A-S, Evin M, Stanová V, Clavel M-A, Barragan P, Rodés-Cabau J, Obadia J, Pibarot P, Rieu R

June 14, 2018 | 10.4244/EIJ-D-17-00875

Longitudinal compression behaviour of coronary stents: a bench-top comparative study

Barragan P, Garitey V, Mouneimne K, Rieu R

April 22, 2014 | 10.4244/EIJV9I12A243

Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

Meredith I, Verheye S, Weissman N, Barragan P, Scott D, Valdés Chávarri M, West N, Kelbæk H, Whitbourn R, Walters D, Kubica J, Thuesen L, Masotti M, Banning A, Sjogren I, Stables R, Allocco D, Dawkins K

July 26, 2013 | 10.4244/EIJV9I3A52

Elective implantation of sirolimus-eluting stents for bifurcated and non-bifurcated unprotected left main coronary artery lesions: clinical outcomes at one year

Barragan P, Fajadet J, Sheiban I, Serruys P, Colombo A, Seabra-Gomes R, Goy J-J, Cook S, Rubino P, Lefèvre T

August 20, 2008

1

Latest news

Atherectomies, in-stent restenosis, stent thrombosis, coronary physiology in TAVI and heart failure

Ahead of print: New technique of percutaneous mitral valvuloplasty

C. Aurigemma et al

Rotational atherectomy and the myth of Sisyphus

Guidance Papers

Guidelines, consensus & position papers

Find the latest trials:

TICAKOREA, PEPCAD NSTEMI, CROSS-AMI, PARTNER-2A 5 years, and more

Fractional flow reserve substitutes in aortic stenosis

Nils P. Johnson

This Week's JAA's: Real-world Use of the Evolut PRO Valve...

Valvular disease